CASE 1 Presentation: 60-year-old African American Woman With GPP
August 17th 2023Erin Boh, MD, presents the case of a 60-year-old African American woman with generalized pustular psoriasis (GPP) covering her medical history, initial presentation, potential disease trigger, highlighting important comorbidities of concern and their impact on treatment selection.
Experts Present Background on JAK Inhibitor vs Systemic Immunosuppressant Safety Study
August 16th 2023Christopher Bunick, MD, PhD, introduces the objectives and design of a study comparing the safety of Janus Kinase (JAK) inhibitors and systemic immunosuppressants in the treatment of atopic dermatitis (AD).
Escalating Treatment From Topical to Systemic in Plaque Psoriasis
August 16th 2023Jennifer Conner, MPAS, PA-C, and Lakshi Aldredge, MSN, ANP-BC, comment on approaches to escalating treatment of plaque psoriasis from topical therapy to systemic therapy and initiating that conversation with the patient.
Importance of Quick Response to Treatment for Patients With Plaque Psoriasis
August 9th 2023Lakshi Aldredge, MSN, ANP-BC, discusses how speed of treatment response guides treatment selection for the patient, taking patient preference into consideration. Jennifer Conner, MPAS, PA-C, comments on treatment failure in plaque psoriasis.